Ventas (VTR) AI Stock Analysis

• Market Cap: $32.03B
• Dividend Yield: 2.76%
• Average Volume (3M): 2.90M
• Price to Earnings (P/E): 158.9
• Beta (1Y): 0.41
• Revenue Growth: 12.45%
• EPS Growth: N/A
• Country: US
• Employees: 498
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.15
• Shares Outstanding: 454,471,200
• 10 Day Avg. Volume: 2,944,786
• 30 Day Avg. Volume: 2,896,390
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 1.31
• Enterprise Value/Revenue: 7.93
• Enterprise Value/Gross Profit: 39.40
• Enterprise Value/Ebitda: 25.87
• 1Y Price Target: $73.14
• Price Target Upside: 6.42% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 7

• Rating: 77 Outperform
• Price Target: $76.00 ▲(10.58% Upside)

The overall stock score is driven by strong earnings growth and positive momentum, supported by robust financial performance and strategic investments. While the high P/E ratio suggests potential overvaluation, the company's growth prospects and dividend yield provide a counterbalance.

Positive Factors

Acquisitions

Acquisition guidance was again increased by $0.5B to $2.0B, indicating strong growth potential.

Earnings

Ventas Inc improved its 2025 outlook for Normalized FFO per share to $3.41, which is a 7% increase year-over-year, led by SHOP.

Negative Factors

Guidance

Shares may initially react negatively given the beat and improved acquisitions without a guidance bump.

Occupancy

Occupancy is below expectations due to elevated mortality rates.

Ventas Business Overview & Revenue Model

Company Description

Ventas, Inc. (VTR) is a leading real estate investment trust (REIT) that primarily focuses on the ownership and management of healthcare, senior housing, and research and innovation properties. The company operates across various sectors including senior housing communities, medical office buildings, life science and innovation centers, and skilled nursing facilities. Ventas is dedicated to providing high-quality real estate solutions to tenants and partners in the healthcare and senior living industries.

How the Company Makes Money

Ventas makes money primarily through leasing its properties to a diverse range of tenants in the healthcare and senior living sectors. The company's revenue model involves collecting rental income from its extensive portfolio of real estate assets, which includes senior housing facilities, medical office buildings, and research and innovation centers. Additionally, Ventas engages in property development and redevelopment, which can enhance the value of its assets and generate additional income. The company may also enter into strategic partnerships and joint ventures to expand its portfolio and explore new revenue opportunities. Ventas is influenced by factors such as demographic trends, healthcare demand, and the regulatory environment, which can impact its occupancy rates and rental income.

Ventas Financial Statement Overview

Summary

Ventas demonstrates steady revenue growth and improving profitability with a robust cash flow management. Despite a substantial debt load typical for REITs, the company's financials are solid with efficient cash generation and effective capital management.

Income Statement

Ventas shows a consistent revenue growth trajectory, with a notable improvement in net income over the TTM period compared to the prior year. The gross profit margin and EBITDA margin indicate robust operational efficiency, although the net profit margin is relatively modest. The EBIT margin is stable, reflecting strong earnings before interest and taxes.

Balance Sheet

The company's balance sheet indicates a substantial debt load with a debt-to-equity ratio above 1, which is common in the REIT industry but still poses potential risks. The equity ratio is moderate, suggesting a balanced capital structure. Return on equity shows improvement, signifying better utilization of equity capital.

Cash Flow

Ventas demonstrates strong cash flow management, with a healthy operating cash flow to net income ratio, indicating efficient conversion of income into cash. Free cash flow growth is positive, supported by disciplined capital expenditures. The free cash flow to net income ratio suggests effective cash generation relative to net earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.30B	4.92B	4.50B	4.13B	3.83B	3.80B
Gross Profit	1.07B	2.10B	770.72M	1.85B	1.74B	1.86B
EBITDA	1.63B	1.87B	1.83B	1.65B	1.60B	1.72B
Net Income	76.08M	81.15M	-40.97M	-40.93M	49.01M	439.15M
Balance Sheet
Total Assets	26.47B	26.19B	24.73B	24.16B	24.72B	23.93B
Cash, Cash Equivalents and Short-Term Investments	614.20M	897.85M	508.79M	122.56M	149.72M	413.33M
Total Debt	0.00	13.74B	13.69B	12.92B	12.22B	12.11B
Total Liabilities	14.55B	15.05B	14.88B	13.94B	13.77B	13.65B
Stockholders Equity	11.53B	10.77B	9.49B	10.15B	10.85B	10.18B
Cash Flow
Free Cash Flow	614.07M	725.78M	935.13M	666.09M	593.15M	921.53M
Operating Cash Flow	1.05B	1.33B	1.12B	1.12B	1.03B	1.45B
Investing Cash Flow	-2.85B	-2.38B	-184.66M	-859.22M	-724.14M	154.29M
Financing Cash Flow	1.43B	1.45B	-543.75M	-283.93M	-558.47M	-1.30B

Ventas Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 68.73
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VTR, the sentiment is Positive. The current price of 68.73 is above the 20-day moving average (MA) of 66.15, above the 50-day MA of 64.26, and above the 200-day MA of 63.43, indicating a bullish trend. The MACD of 1.09 indicates Negative momentum. The RSI at 69.44 is Neutral, neither overbought nor oversold. The STOCH value of 86.84 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VTR.

Ventas Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OHI	78 Outperform	$11.80B	24.95	10.47%	6.71%	12.73%	23.51%
WELL	77 Outperform	$113.34B	140.17	3.48%	1.61%	30.73%	96.48%
CTRE	77 Outperform	$6.29B	35.85	7.02%	3.91%	43.27%	80.97%
VTR	77 Outperform	$32.03B	158.91	1.81%	2.76%	12.45%	―
DOC	66 Neutral	$12.20B	72.01	1.97%	7.63%	15.91%	-49.49%
Sector *	63 Neutral	$6.81B	14.04	-1.43%	7.28%	4.70%	-34.09%
HR	61 Neutral	$5.96B	―	-7.59%	7.50%	-7.16%	23.40%

Ventas Corporate Events

Ventas Amends ATM Sales Agreement to $2.25 Billion

On June 13, 2025, Ventas, Inc. announced an amendment to its ATM Sales Agreement with multiple financial institutions, increasing the aggregate gross sales price of common stock available for issuance to $2.25 billion. This amendment allows Ventas to offer and sell additional shares of common stock, potentially impacting its financial strategy and market presence.

The most recent analyst rating on (VTR) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on Ventas stock, see the VTR Stock Forecast page.

Ventas Realty Issues $500 Million in Senior Notes

On June 3, 2025, Ventas Realty, a subsidiary of Ventas, Inc., successfully issued and sold $500 million in 5.100% Senior Notes due 2032. The proceeds from this offering are intended for general corporate purposes, including debt repayment, which could impact the company’s financial flexibility and market positioning.

The most recent analyst rating on (VTR) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on Ventas stock, see the VTR Stock Forecast page.

Ventas Approves Key Amendments at Annual Meeting

On May 13, 2025, Ventas, Inc. held its Annual Meeting of Stockholders, where key amendments to its Certificate of Incorporation were approved. These amendments include increasing the number of authorized common shares from 600 million to 1.2 billion and limiting the monetary liability of certain officers under Delaware law. The changes aim to enhance corporate governance and provide flexibility for future growth, potentially impacting shareholder value and company operations.

The most recent analyst rating on (VTR) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on Ventas stock, see the VTR Stock Forecast page.